Cargando…

Role of liver biopsy in hepatocellular carcinoma

The role of liver biopsy in the diagnosis of hepatocellular carcinoma (HCC) has been challenged over time by the ability of imaging techniques to characterize liver lesions in patients with known cirrhosis. In fact, in the diagnostic algorithm for this tumor, histology is currently relegated to cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Tommaso, Luca, Spadaccini, Marco, Donadon, Matteo, Personeni, Nicola, Elamin, Abubaker, Aghemo, Alessio, Lleo, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824282/ https://www.ncbi.nlm.nih.gov/pubmed/31686761 http://dx.doi.org/10.3748/wjg.v25.i40.6041

Ejemplares similares

Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
por: Personeni, Nicola, et al.
Publicado: (2021)

The Shifting Paradigm of Prognostic Factors of Colorectal Liver Metastases: From Tumor-Centered to Host Immune-Centered Factors
por: Donadon, Matteo, et al.
Publicado: (2018)

Management of patients with autoimmune liver disease during COVID-19 pandemic
por: Lleo, Ana, et al.
Publicado: (2020)

Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence
por: Milana, Flavio, et al.
Publicado: (2023)

Osteosarcopenia in autoimmune cholestatic liver diseases: Causes, management, and challenges
por: Pugliese, Nicola, et al.
Publicado: (2022)

Risk Stratification of Cholangiocarcinoma Patients Presenting with Jaundice: A Retrospective Analysis from a Tertiary Referral Center
por: Lleo, Ana, et al.
Publicado: (2021)

The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges
por: D’Alessio, Antonio, et al.
Publicado: (2021)

Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells
por: Polidoro, Michela Anna, et al.
Publicado: (2020)

Contemporary role of liver biopsy in hepatocellular carcinoma
por: Sparchez, Zeno, et al.
Publicado: (2018)

Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine
por: Malenica, Ines, et al.
Publicado: (2020)

Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases
por: Costa, Guido, et al.
Publicado: (2021)

Relationship between Epithelial-to-Mesenchymal Transition and Tumor-Associated Macrophages in Colorectal Liver Metastases
por: Gazzillo, Aurora, et al.
Publicado: (2022)

Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases: A Single-Center Review of 847 Patients
por: Milana, Flavio, et al.
Publicado: (2022)

Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
por: Personeni, Nicola, et al.
Publicado: (2019)

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications
por: Personeni, Nicola, et al.
Publicado: (2018)

Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Correction: Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma
por: Lanza, Ezio, et al.
Publicado: (2020)

Targeted agents for second-line treatment of advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2019)

Angiogenesis inhibitors for advanced hepatocellular carcinoma: in search for the right partner
por: Campani, Claudia, et al.
Publicado: (2020)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
por: Personeni, Nicola, et al.
Publicado: (2020)

The impact of antiviral therapy on hepatocellular carcinoma epidemiology
por: Colombo, Massimo, et al.
Publicado: (2018)

Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights
por: Cammarota, Antonella, et al.
Publicado: (2022)

Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma
por: Augello, Claudia, et al.
Publicado: (2009)

The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
por: Labgaa, Ismail, et al.
Publicado: (2021)

Is the exposure to liver transplantation worthwhile for trainees in liver surgery?
por: Donadon, Matteo, et al.
Publicado: (2022)

The Feasibility of Liver Biopsy for Undefined Nodules in Patients under Surveillance for Hepatocellular Carcinoma: Is Biopsy Really a Useful Tool?
por: Renzulli, Matteo, et al.
Publicado: (2022)

Challenging Scenarios and Debated Indications for Laparoscopic Liver Resections for Hepatocellular Carcinoma
por: Berardi, Giammauro, et al.
Publicado: (2023)

Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis
por: Donadon, Matteo, et al.
Publicado: (2020)

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2019)

Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
por: Plaz Torres, Maria Corina, et al.
Publicado: (2019)

Hepatitis C Virus Infection in the Elderly in the Era of Direct-Acting Antivirals: Evidence from Clinical Trials and Real Life
por: Pugliese, Nicola, et al.
Publicado: (2023)

Rapid automated diagnosis of primary hepatic tumour by mass spectrometry and artificial intelligence
por: Giordano, Silvia, et al.
Publicado: (2020)

Benign hepatocellular nodules of healthy liver: focal nodular hyperplasia and hepatocellular adenoma
por: Roncalli, Massimo, et al.
Publicado: (2016)

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
por: Gonvers, Stéphanie, et al.
Publicado: (2022)

Role of microRNAs in hepatocellular carcinoma: a clinical perspective
por: Callegari, Elisa, et al.
Publicado: (2013)

Liver tests abnormalities in COVID-19: trick or treat?
por: Vespa, Edoardo, et al.
Publicado: (2020)

Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant
por: Pagano, Duilio, et al.
Publicado: (2019)

A clinical and pathological update on hepatocellular carcinoma
por: Renne, Salvatore Lorenzo, et al.
Publicado: (2022)

Development of a Deep-Learning Pipeline to Recognize and Characterize Macrophages in Colo-Rectal Liver Metastasis
por: Cancian, Pierandrea, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rf9i9tvddfq17b7nt459s44295